6-bromo-3-(3-ethoxypropyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one, 97%, 100mg

4-Hydroxynicotinic acid, 97.0%, 100g

1-(furan-2-yl)-3-hydroxy-4,4-dimethylpent-2-en-1-one, 98%, 500mg

2,4-Dibromoanisole, 98.0%, 100g

3,3'-Diiodo-L-thyronine, 95.0%, 5mg

{3-[5-(chloromethyl)-2-methanesulfonyl-1H-imidazol-1-yl]propyl}dimethylamine, 95.0%, 10g

(S)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, 95.0%, 100mg

(S)-Ethyl 2-amino-2-phenylacetate hydrochloride, 95.0%, 25g

Methyl 7-amino-2,3-dihydrobenzofuran-4-carboxylate, 97.0%, 250mg

4-Chloro-6-fluoro-2-(trifluoromethyl)quinazoline, 95.0%, 250mg

Adamantanolo, minimo 99%, per sintesi, 10 g, confezione in vetro

1-isobutyl-1H-pyrazole, 5g

(R)-4-methyl-N-((R)-1-(((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide, 98%, 10mg